Stock prices of FMCG and pharma cos are believed to be overheated. However, the majority of these defensive stocks are still fairly valued and quite a few of them look cheaper than their historic valuations. An ET Investor's Guide analysis shows there is more upside left for them.
UR Bhat, MD, Dalton Capital Advisors spoke to ET Now on IT companies, various stocks and markets.
Rajesh Jain, Market Strategist in an interview with ET Now talks about OMCs.
4 prospective midcap steel cos from Angel Broking
**************************
Verge of Break out
YES Bank cmp 299 : Possible Upside after facing lot of resistance at current levels. Good upside expected if breaks 300-310.
Orchid Chem (188): Possible Upside after facing lot of resistance at current levels. Good upside expected if breaks 194-200 levels.
Src: ET, Myiris and etc
No comments:
Post a Comment